ONCO vs BMY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ONCO

49.7
AI Score
VS
ONCO Wins

BMY

43.8
AI Score

Investment Advisor Scores

ONCO

50score
Recommendation
HOLD

BMY

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ONCO BMY Winner
Forward P/E 0 9.3633 Tie
PEG Ratio 0 17.0263 Tie
Revenue Growth -83.9% 5.7% BMY
Earnings Growth 0.0% 153.1% BMY
Tradestie Score 49.7/100 43.8/100 ONCO
Profit Margin 0.0% 18.9% BMY
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ONCO 1M: -55.1% · 3M: -50.3% BMY 1M: +3.5% · 3M: +1.9%

Current Technical Phase

ONCO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.1%), weak momentum, RSI 33

RSI (14): 32.8 · Price: $0.41

BMY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.5 · Price: $63.28

Fundamentals Snapshot

Metric ONCO BMY
Market Cap — —
Forward P/E 0.0 9.2
Trailing P/E 0.0 13.6
Revenue (TTM) — —
Revenue Growth -0.8% 0.1%
Gross Margin 0.8% 0.7%
Operating Margin -131.1% 0.3%
EPS 293.15 4.54
Dividend Yield — 0.04%

Frequently Asked Questions

Based on our detailed analysis, ONCO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.